Bayesian Capital Management’s Avanos Medical AVNS Stock Holding History

Bayesian Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,714	Closed	-$292K	–	779
2022 Q1	$292K	Buy	+8,714	New	+$281K	0.04%	533
2019 Q2	–	Sell	-4,700	Closed	-$201K	–	511
2019 Q1	$201K	Buy	+4,700	New	+$210K	0.04%	474
2018 Q1	–	Sell	-10,403	Closed	-$480K	–	582
2017 Q4	$480K	Buy	+10,403	New	+$478K	0.1%	325
2017 Q1	–	Sell	-5,800	Closed	-$214K	–	406
2016 Q4	$214K	Buy	+5,800	New	+$207K	0.05%	502

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bayesian Capital Management's AVNS Position: Q2 2022 in Review

Bayesian Capital Management sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 8,714 shares — an estimated $292K sold.

Bayesian Capital Management first reported a position in AVNS in Q4 2016 and held it in 4 quarters. The position peaked at $480K in Q4 2017. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

Bayesian Capital Management reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
Bayesian Capital Management sold 8,714 Avanos Medical shares in Q2 2022, an estimated $292K.
Bayesian Capital Management first reported a position in Avanos Medical in Q4 2016 and held it in 4 quarters.
Bayesian Capital Management's Avanos Medical position peaked at $480K in Q4 2017.
287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.